Company Overview
About eGenesis
eGenesis is developing gene-edited pig organs for human transplantation — xenotransplantation — using a 69-gene CRISPR editing protocol that simultaneously knocks out pig genes that trigger human rejection, adds human immune tolerance genes, and eliminates porcine endogenous retroviruses. The company received FDA clearance for its IND for EIGEN-2784 (a gene-edited pig kidney) for end-stage kidney disease, and its first transplant patient remained dialysis-free at more than 7 months post-transplant — the longest reported survival for a xenotransplantation recipient.
Business Model & Competitive Advantage
The 69-gene edit represents the most complex CRISPR modification ever applied to a large animal, developed over a decade of research at Harvard Medical School. The clinical trial now enrolling is pivotal: if positive results are sustained, it would establish gene-edited pig kidneys as a viable alternative to human donor organs — addressing the chronic shortage of 100,000+ patients on the US kidney transplant waiting list, of whom 13 patients die each day awaiting a kidney.
Competitive Landscape 2025–2026
eGenesis's approach is systematically addressing the three barriers to xenotransplantation: hyperacute rejection (pig galactose antigens), chronic rejection (human immune response), and the risk of porcine viral transmission (PERV elimination). The 69-gene protocol represents the most thorough published solution to all three barriers simultaneously, making eGenesis the most clinically advanced xenotransplantation program globally.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
eGenesis is an emerging player bringing innovative solutions to the BioTech market.
Frequently Asked Questions
Not So Random Others
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Adept AI
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and exec
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Plenty
Plenty is a San Francisco-based indoor vertical farming company that uses AI, machine learning, and robotics to grow leafy greens and other produce in controlled indoor environments. The company has r
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
Nira Energy
Nira Energy is a Denver-based renewable energy software company providing grid capacity mapping and interconnection analysis tools that help solar, battery storage, and data center developers identify
Compare eGenesis with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from eGenesis? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim eGenesis Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention eGenesis vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →